Allan Vaag

Allan Vaag is a distinguished academic and clinical expert in endocrinology, currently serving as Coordinator of EXODIAB and Professor of Endocrinology at Lund University since May 2022. Concurrently, Allan holds the position of Affiliated Professor of Type 2 Pathophysiology at Københavns Universitet - University of Copenhagen and serves as a Consultant and Head of Translational Type 2 Diabetes Research at Steno Diabetes Center Copenhagen. With extensive experience in clinical and translational research, Allan has previously held significant roles including Vice President at AstraZeneca, Chief Physician at Rigshospitalet, and Associate Professor at Lund University, contributing to advancements in diabetes care and endocrinology. Allan's educational background includes an MD from Syddansk Universitet and specialized training in endocrinology from The University Hospital of Lund.